| Lab-2-Market Subcommittee |
Committee, Work group, Advisory group, or Task Force |
FDA |
OD/OTT |
The Lab-to-Market (L2M) Subcommittee is an interagency community convened by OSTP to strengthen the Nation’s ability to transition federally funded innovations from the laboratory to the commercial or government marketplace. Maximizing the real world impact of research and development (R&D) to improve lives—regardless whether the research was done at a Federal lab, a university, or a private company—has been a long standing priority of the U.S. Government across multiple Administrations. |
| Leprosy Research Support in Armadillos (Dasypus novemcinctus) |
Other |
HRSA |
NIAID |
The Leprosy Research Support and Maintenance of an Armadillo Colony – Post Genome Era interagency agreement provides standardized research reagents to investigators worldwide to assist in the development of skin test antigens used to detect leprosy. This agreement supports collaborative research to continuously improve biochemical, microbiological, and immunological models for leprosy research in an effort to provide the most up-to-date resource and expertise for mycobacterial researchers. |
| Leveraging Implementation Science to End the HIV Epidemic in the U.S.: Progress and Opportunities for Federal Agencies |
Research Initiative |
CDC, HRSA |
NIAID |
Development of manuscript. |
| Library of Congress Demographic Group Terms (LCDGT) Advisory Board |
Committee, Work group, Advisory group, or Task Force |
SAMHSA |
NLM |
Members of the Library of Congress Demographic Group Terms Advisory Board are appointed for a minimum of two years. Duties include reviewing proposals for new or changed demographic group terms and voting on whether to approve each one. The Advisory Board also discusses and votes on broader topics and policies affecting the development and maintenance of the vocabulary. https://www.loc.gov/aba/publications/FreeLCDGT/freelcdgt.html |
| Linkage of Surveillance, Epidemiology, End Results data to Centers for Medicare and Medicaid data |
Resource Development |
CMS |
NCI |
SEER registry data (e.g., cancer diagnosis date, site, histology) are individually linked to CMS data (e.g., enrollment, claims, assessments and surveys) using personally identifiable information. The data on the matching cancer cases are pulled together with CMS data on non-cancer controls (e.g., individuals not known to have a cancer diagnosis who reside in a SEER area) to create four research data resources: SEER-Medicare, SEER-Medicare Health Outcomes Survey (SEER-MHOS), SEER-Consumer Assessment of Healthcare Providers and Systems (SEER-CAHPS) and SEER-Medicaid. |
| Linkage of Surveillance, Epidemiology, End Results- Medicare to Dept of Housing and Urban Development (HUD) data |
Resource Development |
CMS |
NCI |
SEER registry data (e.g., cancer diagnosis date, site, histology) that are individually linked to CMS Medicare data (e.g., enrollment, claims, assessments and surveys) are then indivdiually linked to HUD housing assistance data. The linkage of these data allows for the examination of the associations between housing assistance status with cancer presentation, treatment, and outcomes. |
| Liquid Biopsy Working Group |
Committee, Work group, Advisory group, or Task Force |
CMS, FDA |
NCI |
This transagency work group meets monthly to review progress in liquid biopsy toward early detection of cancer. Members from several NCI Divisions and Offices, CMS and FDA participate in the meeting. As part of this committee, experts from the extramural community are invited to speak about latest progress in liquid biopsy. |
| Logical Observation Identifiers Names and Codes |
Resource Development |
AHRQ, CDC, CMS, HRSA, IHS, IOS |
NLM |
This activity supports the maintenance, distribution, and continued development of LOINC® (Logical Observation Identifiers Names and Codes), a set of universal codes and names to identify laboratory and other clinical observations and facilitate the exchange and pooling of clinical results for clinical care, outcomes management, public health, and research. NLM collaborates with other federal agencies such as the Agency for Healthcare Research and Quality, CDC, Centers for Medicare and Medicaid Services, Health Resources and Services Administration, Indian Health Service, and the HHS Immediate Office of the Secretary to ensure that LOINC is reviewed and enhanced in ways that meet their needs. http://www.nlm.nih.gov/research/umls/loinc_main.html |
| Long-Term Impact of Military-Relevant Brain Injury (LIMBIC) Consortium/Chronic Effects of Neurotrauma Consortium (GENC) Government Steering Committee |
Committee, Work group, Advisory group, or Task Force |
ACL |
NINDS |
The goals of LIMBIC-CENC are to examine the immediate effects of concussion on the brain as well as those later in life (e.g. risk for dementia), to identify the best treatments for concussion. and to disseminate this information to service members and relevant stakeholders. |
| Lower Limb Prosthetics Research Standards Working Group |
Committee, Work group, Advisory group, or Task Force |
ACL, AHRQ, CMS, FDA |
NICHD |
This working group helps to determine research standards for lower limb prosthetics. |